CEO Today Healthcare Awards

www.ceotodaymagazine.com CEO Today Healthcare Awards 2019 22 USA ABOUT DERMAVANT Dermavant Sciences, a subsidiary of Roivant Sciences, is a clinical-stage biopharmaceutical company dedicated to developing and commercializing innovative therapeutics in medical dermatology. Dermavant leverages the Roivant platform to develop therapies that have the potential to address high unmet medical needs while driving greater efficiency in research and clinical development. The company’s robust medical dermatology pipeline includes both late-stage and early-development product candidates that target specific unmet needs in two of the largest growing immuno- dermatology markets, psoriasis and atopic dermatitis, as well as other large markets, including vitiligo, primary focal hyperhidrosis, and acne. Dermavant is developing its lead product candidate, tapinarof (DMVT-505), as a differentiated therapeutic aryl hydrocarbon receptor modulating agent (TAMA) topical cream for the treatment of plaque psoriasis and atopic dermatitis, which affect approximately 7.5 million and 28 million people in the United States, respectively. ABOUT TODD ZAVODNICK ToddZavodnickhasservedas theChief Executive Officer of Dermavant since November 2018 and as a member of the board of directors since May 2019. Mr. Zavodnick has over 20 years of leadership experience in the biopharmaceutical industry. Prior to joining Dermavant in November 2018, Mr. Zavodnick served as Chief Commercial Officer at Revance. He previously served in global leadership roles at ZELTIQ Aesthetics prior to the company’s acquisition by Allergan, at Galderma Laboratories where he was President and General Manager of North America, and at Alcon Laboratories. He is a member of the board of directors of the Children’s Skin Disease Foundation and Allurion. Mr. Zavodnick received a B.S. in Pharmacy from Rutgers University and an M.B.A. from The University of Texas at Dallas. TODD ZAVODNICK CEO of Dermavant CONTACT Investor Relations & Corporate Communications Kara Stancell 520-858-0027 kara.stancell@dermavant.com Long Beach, California Office Dermavant Sciences, Inc. 3780 Kilroy Airport Way, Suite 250 Long Beach, CA 90806 Durham, North Carolina Office Dermavant Sciences, Inc. 359 Blackwell St, Suite 240 Durham, NC 27701 “Truly great people combined with great products is a recipe for success, with patients at the center of it all.” “Our mission is to develop and commercialize innovative therapies for a variety of medical dermatologic indications that address significant unmet medical needs with the goal of improving patients’ lives.” www.dermavant.com